Status | Study |
Completed |
Study Name: A Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2023-01-17 Interventions: Interventional |
NOT_YET_RECRUITING |
Study Name: Imaging Retinal Vasculature in Infant Eyes Condition: Retinopathy of Prematurity Date: 2022-09-06 Interventions: OCT systems are in vivo optical imaging technology that allows non-contact imaging of early-stage ocular pathology.They create real-time, non |
Not yet recruiting |
Study Name: Propranolol for Prevention of Threshold Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2017-03-13 Interventions: Drug: Propranolol Oral propran |
Not yet recruiting |
Study Name: a Prospective Cohort Study for Propranolol Treatment in Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2017-01-19 Interventions: Drug: Propranolol Oral propran |
Recruiting |
Study Name: Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants Condition: Retinopathy of Prematurity Date: 2016-06-29 Interventions: Other: RETCAM Biological: Blood samples |
Recruiting |
Study Name: Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey Condition: Retinopathy of Prematurity Date: 2016-06-14 |
Completed |
Study Name: A Fatty Acids Study in Preventing Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2016-03-30 Interventions: Drug: SMOFlipid Parenteral fat |
Enrolling by invitation |
Study Name: Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2016-02-05 Interventions: Dietary Supplement: docosahexaenoic acid |
Recruiting |
Study Name: RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2015-02-18 Interventions: Drug: Ranibizumab 0.2 mg Intra |
Recruiting |
Study Name: Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity Condition: Retinopathy of Prematurity Date: 2015-02-17 Interventions: Drug: Bevacizumab Varying dosages in 10µl Other |